ICCC
Price
$4.58
Change
+$0.12 (+2.69%)
Updated
Dec 8, 6:59 PM EST
72 days until earnings call
NKTX
Price
$2.73
Change
-$0.04 (-1.44%)
Updated
Dec 8, 6:59 PM EST
96 days until earnings call
Ad is loading...

ICCC vs NKTX ᐉ Comparison: Which is Better to Invest?

Header iconICCC vs NKTX Comparison
Open Charts ICCC vs NKTXBanner chart's image
ImmuCell
Price$4.58
Change+$0.12 (+2.69%)
Volume$7.75K
CapitalizationN/A
Nkarta
Price$2.73
Change-$0.04 (-1.44%)
Volume$224.73K
CapitalizationN/A
View a ticker or compare two or three
ICCC vs NKTX Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
ICCC vs. NKTX commentary
Dec 10, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICCC is a Hold and NKTX is a Hold.

COMPARISON
Comparison
Dec 10, 2023
Stock price -- (ICCC: $4.55 vs. NKTX: $2.73)
Brand notoriety: ICCC and NKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ICCC: 98% vs. NKTX: 13%
Market capitalization -- ICCC: $36.2M vs. NKTX: $124.15M
ICCC [@Biotechnology] is valued at $36.2M. NKTX’s [@Biotechnology] market capitalization is $124.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICCC’s FA Score shows that 0 FA rating(s) are green whileNKTX’s FA Score has 1 green FA rating(s).

  • ICCC’s FA Score: 0 green, 5 red.
  • NKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, NKTX is a better buy in the long-term than ICCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ICCC’s TA Score shows that 2 TA indicator(s) are bullish while NKTX’s TA Score has 4 bullish TA indicator(s).

  • ICCC’s TA Score: 2 bullish, 7 bearish.
  • NKTX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, NKTX is a better buy in the short-term than ICCC.

Price Growth

ICCC (@Biotechnology) experienced а +1.56% price change this week, while NKTX (@Biotechnology) price change was +0.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10161.68%. For the same industry, the average monthly price growth was +8.48%, and the average quarterly price growth was +27.10%.

Reported Earning Dates

ICCC is expected to report earnings on Feb 20, 2024.

NKTX is expected to report earnings on Mar 15, 2024.

Industries' Descriptions

@Biotechnology (+10161.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ICCC with price predictions.
OPEN
A.I.dvisor published
a Summary for NKTX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
NKTX($124M) has a higher market cap than ICCC($36.2M). ICCC YTD gains are higher at: -25.410 vs. NKTX (-54.424). ICCC has higher annual earnings (EBITDA): -3.25M vs. NKTX (-131.1M). NKTX has more cash in the bank: 276M vs. ICCC (1.99M). ICCC has less debt than NKTX: ICCC (16.7M) vs NKTX (89.5M). ICCC has higher revenues than NKTX: ICCC (16.3M) vs NKTX (0).
ICCCNKTXICCC / NKTX
Capitalization36.2M124M29%
EBITDA-3.25M-131.1M2%
Gain YTD-25.410-54.42447%
P/E Ratio153.85N/A-
Revenue16.3M0-
Total Cash1.99M276M1%
Total Debt16.7M89.5M19%
FUNDAMENTALS RATINGS
ICCC: Fundamental Ratings
ICCC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ICCCNKTX
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
N/A
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
Bearish Trend 10 days ago
76%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 7 days ago
86%
Bullish Trend 3 days ago
73%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLYS7.180.28
+4.06%
Mineralys Therapeutics
AON324.102.41
+0.75%
Aon plc
REFR1.01N/A
N/A
Research Frontiers
VVV35.05-0.06
-0.17%
Valvoline
SAGE20.01-0.88
-4.21%
Sage Therapeutics